Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Net loss: €5.59m (down from €113.1k profit in 3Q 2023). €0.13 loss per share (down from €0.002 profit in 3Q 2023). All ...

Indian equities have surged in recent years driven by strong macro environment, corporate earnings, and domestic equity ...

Chennai police have successfully apprehended two suspects involved in the kidnapping of a pharmaceutical staff member due to ...

The Delhi High Court recently observed that courts need to be more stringent and cautious while dealing with cases involving ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2024 of $0.21 per Class A ...

Lawmakers accused EPSS of illicitly selling medicines and pharmaceutical supplies imported using public funds to private ...

BALLERUP, Denmark-- ( BUSINESS WIRE )--LEO Pharma today announced its commitment to achieving a net-zero climate target by ...

India may benefit from the US restricting investments in China, leading global companies to reduce exposure there. This shift ...